Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

Kidney Cancer Publications

Following is a cumulative list of Hoosier Cancer Research Network publications in kidney cancer.

Manuscripts and Journal Articles

  • Pal SK, Azad AA, Bhatia S, Drabkin HA, Costello B, Sarantopoulos J, Kanesvaran R, Lauer R, Starodub AN, Hauke RJ, Sweeney CJ, Hahn NM, Sonpavde G, Richey S, Breen T, Kremmidiotis G, Leske AF, Doolin E, Bibby DC, Simpson J, Iglesias J, Hutson TE. A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC) GU09-145. Clin Cancer Res. 2015 Mar 18. pii: clincanres.3370.2014. [Epub ahead of print] PMID: 25788492
  • Zon R, McClean J, Helman D, Ansari R, Picus J, Sandler A, Williams S, Loehrer Sr P.
    Altretamine For the Treatment of Metastatic Renal Cell Carcinoma: A Hoosier Oncology Group Trial GU91-1. Invest New Drugs 19(3):229-231, August 2001
  • Murphy BR, Rynard SM, Pennington KL, Grosh W, Loehrer PJ. A Phase II Trial of Vinblastine plus Dipyridamole in Advanced Renal Cell Carcinoma: A Hoosier Oncology Group Study GU88-1. Am J Clin Oncol(CCT) 17(1):10-13, 1994.
  • Murphy BR, Rynard SM, Einhorn LH, Loehrer PJ: A Phase II Trial of Interferon Alpha-2A Plus Fluorouracil in Advanced Renal Cell Carcinoma: A Hoosier Oncology Group Study GU90-1. Invest New Drugs 10:225-230, 1992.
  • Inhorn L, Williams SD, Nattam S, Stephens D: High Dose Cimetidine for Treatment of Metastatic Renal Cell Carcinoma: A Hoosier Oncology Group Study. Am J Clin Oncol 15:157-159, 1992.

Abstracts, Posters, and Presentations

  • TE Hutson, LH Dang, RC Lauer, A Starodub, RJ Hauke, T Logan, KA Bylow, MD Galsky, DC Bibby, G Kremmidiotis, EE Doolin, TC Lavranos, AF Leske, NM Hahn, G Sonpavde, C Sweeney, J Sarantopoulos. Phase I/II study of a BNC105P/everolimus regimen for progressive metastatic renal cell carcinoma (mRCC) following prior tyrosine kinase inhibitors: Hoosier Oncology Group GU09-145. Accepted to the General Poster Session E at the ASCO 2012 Genitourinary Cancers Symposium, February 2-4, 2012, San Francisco, CA. J Clin Oncol 30, 2012 (suppl 5; abstr 373)
  • TE Hutson, LH Dang, RC Lauer, A Starodub, RJ Hauke, MD Galsky, KA Bylow, T Logan, CL Cowey, DC Bibby, G Kremmidiotis, EE Doolin, TC Lavranos, G Sonpavde, NM Hahn, C Sweeney, J Sarantopoulos. Phase I results of a phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC) patients previously treated with VEGFR tyrosine kinase inhibitors: Hoosier Oncology Group GU09-145. Accepted to the General Poster Session at the ASCO Annual Meeting, June 1-5, 2012, Chicago IL. J Clin Oncol 30, 2012 (suppl; abstr 4603)
  • T.E. Hutson, J. Sarantopoulos, T. Logan, G. Sonpavde, M.D. Galsky, C. Sweeney D.C. Bibby, G. Kremmidiotis , E.E. Doolin, N.M. Hahn. Phase I/II study of BNC105P in combination with everolimus or following everolimus for progressive metastatic renal cell carcinoma following prior tyrosine kinase inhibitors.:Hoosier Oncology Group GU09-145. Accepted to the Trial in Progress Poster Session at the ASCO Annual Meeting, June 4-8 2011, Chicago, IL. J Clin Oncol 29: 2011 (suppl; abstr TPS194)
  • Pennington K, Gordon M, Picus J. A Phase II Trial of Liposomal Doxil in the Treatment of Advanced Renal Cell Cancer: A Hoosier Oncology Group (HOG) Study GU94-1. Accepted to the ASCO annual meeting May 16-19, 1998, Los Angeles, CA.
  • Picus J, Walker PR, Webb C, Gonin R, Woodrupp J, McClean J. A Phase II Hoosier Oncology Group Study of Levamisole in the Treatment of Advanced Renal Cell Cancer: A Hoosier Oncology Group and Walther Cancer Institute Trial GU94-1. Accepted to the ASCO Annual Meeting May 18-21, 1996, Philadelphia, PA.
  • McClean J, Loehrer P, Picus J, Ansari R, Mitchell E, Reynolds R, Capizzi R. A Phase II Study of Altretramine for the Treatment of Metastatic Renal Cell Carcinoma: A Hoosier Oncology Group, Walther Cancer Institute, and US Bioscience Trial GU91-1. Accepted to the ASCO Annual Meeting, May 14th – 17th, 1994, Dallas, Texas.
  • Murphy B, Rynard S, Einhorn L, Loehrer PJ: A Phase II Trial of Interferon Alpha-2A Plus 5-Fluorouracil in Advanced Renal Cell Carcinoma: A Hoosier Oncology Group Study GU90-1. Proc Am Fed Clinical Research: 1991.
  • Murphy B, Rynard S, Pennington K, Grosh W, Loehrer PJ: A Phase II Trial of Vinblastine (VLB) plus Dipyridamole (DP) in Advanced Renal Cell Carcinoma (RCC): A Hoosier Oncology Group Study GU88-1. Proc Am Soc Clin Oncol 10: 1991.
  • Inhorn L, Pennington K, Miller M, Meyer S, Stephens D, Williams S: Phase II Study of High Dose Cimetidine in Renal Cell Carcinoma: A Trial of the Hoosier Oncology Group. Proc Am Soc Clin Oncol 8:l48, l989.